Home Cart 0 Sign in  
X

[ CAS No. 16694-18-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 16694-18-1
Chemical Structure| 16694-18-1
Chemical Structure| 16694-18-1
Structure of 16694-18-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 16694-18-1 ]

Related Doc. of [ 16694-18-1 ]

Alternatived Products of [ 16694-18-1 ]

Product Details of [ 16694-18-1 ]

CAS No. :16694-18-1 MDL No. :MFCD03422294
Formula : C5H3BrO2S Boiling Point : -
Linear Structure Formula :- InChI Key :HJZFPRVFLBBAMU-UHFFFAOYSA-N
M.W : 207.05 Pubchem ID :610409
Synonyms :

Calculated chemistry of [ 16694-18-1 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 38.98
TPSA : 65.54 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.04 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.48
Log Po/w (XLOGP3) : 2.15
Log Po/w (WLOGP) : 2.21
Log Po/w (MLOGP) : 1.35
Log Po/w (SILICOS-IT) : 2.62
Consensus Log Po/w : 1.96

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -2.82
Solubility : 0.311 mg/ml ; 0.0015 mol/l
Class : Soluble
Log S (Ali) : -3.16
Solubility : 0.144 mg/ml ; 0.000694 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.9
Solubility : 2.61 mg/ml ; 0.0126 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.25

Safety of [ 16694-18-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 16694-18-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 16694-18-1 ]
  • Downstream synthetic route of [ 16694-18-1 ]

[ 16694-18-1 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 16694-18-1 ]
  • [ 64-17-5 ]
  • [ 62224-17-3 ]
YieldReaction ConditionsOperation in experiment
89%
Stage #1: Reflux
Stage #2: With sodium hydrogencarbonate In water at 20℃;
Example 7A
Ethyl 4-bromothiophene-2-carboxylate
663 mg (3.20 mmol) of the compound from Example 6A are provided in 25 ml of ethanol, 0.1 ml of concentrated sulfuric acid is added and the mixture is heated under reflux overnight.
After cooling to room temperature, a saturated aqueous sodium bicarbonate solution is added and the mixture is diluted with water and extracted with ethyl acetate.
The organic phase is dried over sodium sulfate, filtered and concentrated. 700 mg (89percent of theory) of the title compound are obtained.
1H-NMR (400 MHz, DMSO-d6): δ=8.07 (d, 1H), 7.78 (d, 1H), 4.30 (q, 2H), 1.30 (t, 3H).
GC-MS (Method 11): Rt=4.69 min; MS (EIpos): m/z=234 [M]+.
Reference: [1] Patent: US2012/22123, 2012, A1, . Location in patent: Page/Page column 13
  • 2
  • [ 16694-18-1 ]
  • [ 62224-17-3 ]
Reference: [1] Nippon Kagaku Zasshi, 1959, vol. 80, p. 1021,1023[2] Chem.Abstr., 1961, p. 5467
[3] Patent: US2010/184649, 2010, A1,
  • 3
  • [ 16694-18-1 ]
  • [ 62224-16-2 ]
YieldReaction ConditionsOperation in experiment
98% With sulfuric acid In methanol at 65℃; for 17 h; A few drops of concentrated sulphuric acid are added to a solution of 5.0 g of the compound obtained during Stage 1 of Preparation 1 in 25 ml of methanol. The reaction medium is stirred at 65° C. for 17 hours and is then concentrated under reduced pressure. The oily residue obtained is dissolved in ethyl acetate (200 ml), washed with water (3.x.100 ml), dried over sodium sulphate and then concentrated under reduced pressure in order to produce 5.24 g of the desired product. Yield: 98percent 1H NMR (CDCl3) δ (ppm): 3.90 (s, 3H), 7.45 (s, 1H), 7.70 (s, 1H)
95% With thionyl chloride In methanol; dichloromethane b)
Methyl 4-bromothiophene-2-carboxylate

To a cooled (-20° C.) solution of 6.02 g (29.1 mmol) of 4-bromothiophene-2-carboxylic acid (as prepared in the previous step) in 100 mL of anhyd MeOH under nitrogen was added 2.55 mL (34.9 mmol) of thionyl chloride dropwise at a rate to keep the temperature below -5° C. (ca. 8-10 min).
After stirring for 1 h at room temperature, the mixture was refluxed for 8 h, cooled, and concentrated in vacuo.
The resulting 6.7 g of pale amber oil was passed through a 150 g pad of silica gel with ca. 600 mL of CH2Cl2 (discarding the first 120 mL which contained a minor impurity) to afford, after concentration in vacuo, the title compound as a colorless oil (6.11 g, 95percent).
1H-NMR (300 MHz, CDCl3) δ7.69 (d, 1 H, J=1.5 Hz), 7.45 (d, 1 H, J=1.5 Hz), and 3.90 (s, 3 H).
95% With thionyl chloride In methanol; dichloromethane b)
Methyl 4-bromothiophene-2-carboxylate

To a cooled (-20° C.) solution of 6.02 g (29.1 mmol) of 4-bromothiophene-2-carboxylic acid (as prepared in the previous step) in 100 mL of anhyd MeOH under nitrogen was added 2.55 mL (34.9 mmol) of thionyl chloride dropwise at a rate to keep the temperature below -5° C. (ca. 8-10 min).
After stirring for 1 h at room temperature, the mixture was refluxed for 8 h, cooled, and concentrated in vacuo.
The resulting 6.7 g of pale amber oil was passed through a 150 g pad of silica gel with ca. 600 mL of CH2Cl2 (discarding the first 120 mL which contained a minor impurity) to afford, after concentration in vacuo the title compound as a colorless oil (6.11 g, 95percent).
1H-NMR (300 MHz, CDCl3) δ 7.69 (d, 1H, J=1.5 Hz), 7.45 (d, 1H, J=1.5 Hz), and 3.90 (s, 3H).
95% With thionyl chloride In methanol; dichloromethane b
4-Bromothiophene-2-carboxylic acid Methyl Ester
To a dry flask under N2 with a stirbar was added 6 g (29.1 mmol) of 4-bromothiophene-2-carboxylic acid (as prepared in the previous step) and dry methanol (100 mL).
The solution was cooled in an ice-salt bath for 15 min and 2.55 mL (34.9 mmol) of thionyl chloride was added over 15 min, keeping the temperature <-5° C.
The reaction mixture was stirred on the ice-salt bath for an additional 15 min, then for 1 h at rt, and finally refluxed for 8 h under N2.
The resulting solution was cooled and concentrated to 6.7 g of pale amber oil.
This oil was passed through 150 g of silica with ~600 mL CH2Cl2 (discarded the first 120 mL which contained minor impurities and no ester).
The solvent was removed in vacuo to afford 6.11 g (95percent yield) of the title compound as a colorless solid, which was used in the next step without further purification.

Reference: [1] Patent: US2004/72871, 2004, A1, . Location in patent: Page/Page column 29
[2] Patent: US2002/37915, 2002, A1,
[3] Patent: US6291514, 2001, B1,
[4] Patent: US2004/9995, 2004, A1,
[5] Archiv der Pharmazie, 1998, vol. 331, # 12, p. 405 - 411
  • 4
  • [ 67-56-1 ]
  • [ 16694-18-1 ]
  • [ 62224-16-2 ]
YieldReaction ConditionsOperation in experiment
100% at 25 - 50℃; for 12 h; To a solution of 4-bromo-2-thiophenecarboxylic acid (4g, 19 mmol) in MeOH (100 ml.) was added H2SO4 (5 ml.) dropwise at 25 0C. The solution was stirred for 12 h at 50 0C and was poured into ice-H2O and the pH was adjusted to ~1 1 with aqueous NaOH. The aqueous phase was extracted several times with DCM and the combined organic fractions were dried over Na2SO4, concentrated and used directly (4.27g, quant.): LCMS (ES) m/z 222 (M+H)+.
100% at 50℃; Example 1; Preparation of Λ/-{(1 S)-2-amino-1-[(3,4-difluorophenyl)methyl1ethyl}-4-(1 /-/-pyrazol-4-yl)-2- thiophenecarboxamide; a) methyl 4-bromo-2-thiophenecarboxylate; To a solution of 4-bromo-2-thiophenecarboxylic acid (7 g, 34 mmol) in MeOH (170 ml.) was added cone. H2SO4 (17 ml_). After heating to 50 0C for 12 h, the reaction solution was cooled to room temperature and diluted with CHCI3 (100 ml_). The CHCI3 solution was washed with cold aqueous NaHCO3, then 5N NaOH and dried over Na2SO4. Concentration under vacuum gave the title compound as a yellow oil (7.2 g, quant.): LCMS (ES) m/z 222 (M+H)+.
95%
Stage #1: at -5℃; for 0.75 h;
Stage #2: at 20℃; for 1 h;
Stage #3: for 8 h; Heating / reflux
To a dry flask under N2 with a stirbar was added 6 g (29.1 mmol) of 4- bromothiophene-2-carboxylic acid (as prepared in the previous step) and dry methanol (100 mL). The solution was cooled in an ice-salt bath for 15 min and 2.55 mL (34.9 mmol) of thionyl chloride was added over 15 min, keeping the temperature <-5o C. The reaction mixture was stirred on the ice-salt bath for an additional 15 min, then for 1 h at rt, and finally refluxed for 8 h under N2. The resulting solution was cooled and concentrated to 6.7 g of pale amber oil. This oil was passed through 150 g of silica WITH ~600 mL CH2C12 (discarded the first 120 mL which contained minor impurities and no ester). The solvent was removed in vacuo to afford 6.11 g (95percent yield) of the title compound as a colorless solid, which was used in the next step without further purification.
91.4% for 6 h; Reflux In 100ml single neck flask was added 4-bromo-2-thiophenecarboxylic acid 2.07g (10mmol), thionyl chloride 1.19g (10mmol) and absolute ethanol 25ml, refluxed, 6h After TLC showed the starting material is no longer remaining. The solvent was distilled off under reduced pressure, ice water was added, adjusting the pH with saturated sodium carbonate solution to 9 to 10, and extracted with ethyl acetate (40ml × 3), the combined organic phase was washed twice with saturated brine, dried over anhydrous MgSO 4, pale yellow oily liquid 2.02g, yield 91.4percent.
90% for 10 h; Heating / reflux Example 1 : Methyl 4-{6-[4-(2-piperidin-l-ylethoxy)phenyllpyrazolo[l,5-alpyrimdin-3-vUthiophene- 2-carboxylate; Step 1 : methyl 4-(4,4,5,5-tetramethyl-l,3,2-dioxaborolan-2-yl)thiophene-2-carboxylate; 4-Bromothiophene-2-carboxylic acid (0.418 g, 2 mmol) was dissolved in methanol (1 mL), and concentrated sulfuric acid (0.039 g, 0.4 mmol) was added. The mixture was refluxed for 1O h, poured into water, and subjected to 3-fold extraction with ethyl acetate. The organic layer was washed with K2CO3- solution, concentrated, dried over MgSO4, filtered and evaporated to give methyl 4-bromothiophene-2- carboxylate, weight 0.4 g (90percent yield).A flask containing PdCl2(dppf) (0.32 g, 0.43 mmol), dppf (0.24 g, 0.43 mmol), KOAc (4.23 g, 0.043 mol), and pinacolediborone (5.5 g, 0.021 mol) was flushed with argon, then a solution of the ester from the foregoing step (3.2 g, 0.014 mol) in dioxane (60 mL) was added. The mixture was stirred at 850C under argon atmosphere for 40 h. Water (5-fold excess) was added, and the mixture was subjected to 3-fold extraction with ethyl acetate. The organic layer was washed with brine, concentrated, dried over MgSO4, filtered, and evaporated to give the crude methyl 4-(4,4,5,5-tetramethyl-l,3,2-dioxaborolan-2-yl)thiophene- 2-carboxylate (5.1 g, purity 85percent according to 1H NMR data). This crude boronate was used without further purification.

Reference: [1] Patent: WO2008/98104, 2008, A1, . Location in patent: Page/Page column 134
[2] Patent: WO2010/93885, 2010, A1, . Location in patent: Page/Page column 37-38
[3] Bioorganic and Medicinal Chemistry Letters, 2002, vol. 12, # 3, p. 491 - 495
[4] Patent: WO2003/99805, 2003, A1, . Location in patent: Page 151
[5] Patent: CN103408540, 2016, B, . Location in patent: Paragraph 0100; 0164; 0165
[6] Patent: WO2007/85873, 2007, A1, . Location in patent: Page/Page column 18
[7] Journal of Medicinal Chemistry, 1992, vol. 35, # 6, p. 1109 - 1116
[8] Journal of Chemical Research, Miniprint, 1981, # 5, p. 1801 - 1824
[9] Patent: WO2005/40161, 2005, A1, . Location in patent: Page/Page column 78
[10] Patent: CN108341774, 2018, A, . Location in patent: Paragraph 0531-0534
  • 5
  • [ 16694-18-1 ]
  • [ 18107-18-1 ]
  • [ 62224-16-2 ]
Reference: [1] Journal of Medicinal Chemistry, 2016, vol. 59, # 23, p. 10435 - 10450
  • 6
  • [ 16694-18-1 ]
  • [ 60729-37-5 ]
YieldReaction ConditionsOperation in experiment
79% With N-chloro-succinimide In N,N-dimethyl-formamide at 50℃; for 10 h; To a solution of 4-bromo-2-thiophenecarboxylic acid (2.07 g, 10 mmol) in DMF (5 ml.) was added NCS (2.7 g, 15 mmol) in one portion. The reaction mixture was stirred at 50 0C for 10 h, and then cooled to room temperature. The desired product precipitated after water (5 ml.) was added. The white solid was filtered and dried under high vacuum to give 1.9 g (79percent). LC-MS (ES) m/z =242 (M+H)+,
Reference: [1] Patent: WO2008/98104, 2008, A1, . Location in patent: Page/Page column 177
  • 7
  • [ 16694-18-1 ]
  • [ 83933-17-9 ]
YieldReaction ConditionsOperation in experiment
78%
Stage #1: With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; for 2 h;
Stage #2: With ammonia In water; N,N-dimethyl-formamide at 0 - 20℃; for 5 h;
A solution of 4 bromo-thiophene-2-carbo xylic acid (2.Og, 9.66mmol), l-ethyl-3-(3'- dimethylaminopropyl)carbodiimide hydrochloride (2.04g, 10.63mmol) and 1 -hydroxybenzotriazole hydrate (1.44g, 10.63mmol) in DMF (2OmL) is stirred at room temperature for 2 hours. The reaction mixture is then cooled to O0C and aq. NH3 (ImL, 17.3mmol) is added. The mixture is stirred at room temperature for an additional 5 hours, then water is added to the reaction mixture and the resultant precipitate is collected by filtration and washed with IM NaOH, H2O and petroleum ether. The title compound is isolated as a white solid (1.56g, 78percent).
8 g With N-hydroxybenzotriazole ammonium salt; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In acetonitrile A) 4-bromothiophene-2-carboxamide [0504] To a solution of 4-bromothiophene-2-carboxylic acid (15 g), HOBt ammonium salt (16.5 g) and triethylamine (20.08 mL) in acetonitrile (250 mL) was added EDCI hydrochloride (16.87 g), and the mixture was stirred overnight. The reaction mixture was washed with saturated aqueous sodium bicarbonate solution and saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate/hexane) to give the title compound (8.0 g). 1H NMR (300 MHz, CDCl3) δ 5.87 (2H, brs), 7.43 (2H, q, J = 1.4 Hz)
Reference: [1] Patent: WO2007/138072, 2007, A2, . Location in patent: Page/Page column 47
[2] Patent: EP2857400, 2015, A1, . Location in patent: Paragraph 0504
  • 8
  • [ 16694-18-1 ]
  • [ 868387-45-5 ]
YieldReaction ConditionsOperation in experiment
77% With diphenyl phosphoryl azide; triethylamine In <i>tert</i>-butyl alcohol at 100℃; for 5 h; To the solution of 4-bromothiophene-2-carboxylic acid (3.0 g, 14.5 mmol) in 36 mL of anhydrous t-BuOH were added DPPA (4.06 mL, 18.8 mmol) and Et3N (4.04 mL, 29.0 mmol). The reaction was stirred at 100°C for 5h. Upon completion (monitored by HPLC), the solvent was removed and the crude product was purified by Combiflash silica gel chromatography (0-5percent of EtOAc in hexane), which provided 3.10 g (77percent) of the title compound 51 as a white solid. 1H NMR (400 MHz, CDCl3) δ= 7.04 (br. s., 1H), 6.73 (dd, J = 1.8 Hz, 0.4 Hz, 1H), 6.44 (d, J=1.8 Hz, 1H), 1.52 (s, 9H).
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2018, vol. 28, # 19, p. 3210 - 3215
  • 9
  • [ 16694-18-1 ]
  • [ 75-65-0 ]
  • [ 868387-45-5 ]
YieldReaction ConditionsOperation in experiment
60% at 85℃; for 15 h; To a mixture of 5-bromothiophenecarboxylic acid (24.2 mmoles, 5.0 g) in t- BuOH (20 ml_) was added DPPA (31.4 mmoles, 6.8 mL) and triethyl amine (72.6 mmole, 10.1 mL). The mixture was heated to 85 °C for 15 h under an atmosphere of N2. After cooling to RT, the reaction was concentrated in vacuo. Flash chromatography (silica gel, hexanes/EtOAc, 4:1 )) gave the title compound (4.0 g, 60percent) as a tan foam. LCMS (ES) m/z 278 (M+H)+.
55% for 5 h; Heating / reflux tert-Butyl4-bromothiophen-2-ylcarbamate:; 4-Bromothiophene-2-carboxylic acid (1.75 g, 8.5 mmol) was dissolved in 40 mL of t- BuOH. To this solution diphenylphosphoryl azide (2.8 g, 10.2 mmol) and triethylamine (1.4 mL, 10.1 mmol) were added. The reaction mixture was heated to reflux for 5 hours, cooled room temperature, and diluted with EtOAc. The organic layer was washed with 10percent citric acid, saturated sodium bicarbonate and brine, and concentrated to an oil, which was purified by column chromatography on silica (0 to 25percent EtOAc/hexanes) to give the product, 1.3 g, 4.7 mmol, 55percent. 1H NMR 500 MHz (CDC13) 6.96 (lH, br s), 6.83 (lH, s), 6.43 (1H, s), 1.54 (9H, s).
Reference: [1] Journal of Medicinal Chemistry, 2015, vol. 58, # 12, p. 5028 - 5037
[2] Patent: WO2007/76423, 2007, A2, . Location in patent: Page/Page column 65
[3] Patent: WO2005/103050, 2005, A2, . Location in patent: Page/Page column 183-184
[4] Patent: US2007/270386, 2007, A1, . Location in patent: Page/Page column 36
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 16694-18-1 ]

Bromides

Chemical Structure| 29421-99-6

[ 29421-99-6 ]

4-Bromo-5-methylthiophene-2-carboxylic acid

Similarity: 0.95

Chemical Structure| 62224-16-2

[ 62224-16-2 ]

Methyl 4-bromothiophene-2-carboxylate

Similarity: 0.91

Chemical Structure| 7311-64-0

[ 7311-64-0 ]

3-Bromothiophene-2-carboxylic acid

Similarity: 0.91

Chemical Structure| 26137-08-6

[ 26137-08-6 ]

Methyl 3-bromothiophene-2-carboxylate

Similarity: 0.84

Chemical Structure| 60729-37-5

[ 60729-37-5 ]

4-Bromo-5-chlorothiophene-2-carboxylic acid

Similarity: 0.80

Carboxylic Acids

Chemical Structure| 29421-99-6

[ 29421-99-6 ]

4-Bromo-5-methylthiophene-2-carboxylic acid

Similarity: 0.95

Chemical Structure| 7311-64-0

[ 7311-64-0 ]

3-Bromothiophene-2-carboxylic acid

Similarity: 0.91

Chemical Structure| 60729-37-5

[ 60729-37-5 ]

4-Bromo-5-chlorothiophene-2-carboxylic acid

Similarity: 0.80

Chemical Structure| 4282-31-9

[ 4282-31-9 ]

Thiophene-2,5-dicarboxylic acid

Similarity: 0.79

Chemical Structure| 1918-79-2

[ 1918-79-2 ]

5-Methylthiophene-2-carboxylic acid

Similarity: 0.79